This inventor holds 11 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2014-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2014 - 2017)
- Fujisawa, JP (2017)
- Kanagawa, JP (2014 - 2020)
- New York, NY (US) (2018 - 2022)
Company Filing History:
Years Active: 2014-2022
Title: **The Innovative Journey of Makoto Fushimi**
Introduction
Makoto Fushimi, a prominent inventor based in Kanagawa, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 11 patents, he is known for his innovative work that holds promise in treating various medical conditions.
Latest Patents
Among his latest inventions are two noteworthy patents. The first is a Heterocyclic compound aimed at providing a potential solution for the prophylaxis or treatment of constipation. This compound, described in detail in his patent specification, offers a specialized chemical structure that may play a crucial role in therapeutic applications. The second patent pertains to an Aromatic ring compound, which acts as a cholinergic muscarine M1 receptor positive allosteric modulator. This compound is particularly valuable for medical treatments related to Alzheimer's disease, schizophrenia, pain management, sleep disorders, and Parkinson's disease dementia, among others.
Career Highlights
Makoto Fushimi is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda has allowed him to focus on the development of innovative therapeutics aimed at addressing complex health challenges. His extensive experience and commitment to research have contributed to the advancement of medical science.
Collaborations
Throughout his career, Makoto has collaborated with notable colleagues such as Takahiko Taniguchi and Masato Yoshikawa. These partnerships reflect a team-oriented approach in pursuing groundbreaking innovations and enhancing the impact of their research initiatives.
Conclusion
Makoto Fushimi continues to be a driving force in pharmaceutical innovation. His dedication to developing new therapeutic compounds showcases the importance of inventors in the pursuit of better healthcare solutions. As his career progresses, the medical community looks forward to the potential breakthroughs that may emerge from his ongoing research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile